Naibec Confirms Potential to Regenerate Jawbone and Tooth Supporting Tissue
Predicted impact: Low
Early preclinical finding on tissue regeneration; far from commercial revenue, vague impact.
Nibec나이벡
138610 · KOSDAQ · ₩138610 · 나이벡
₩14,580 ₩0 (0.00%)End-of-day · Oct 28, 2026 · End-of-day prices.
Nyvec confirms potential to alleviate kidney and heart fibrosis, unveils preclinical data at US conference
Predicted impact: Low
Preclinical data at a conference is early-stage and vague for valuation.
Also known as: Nibec / 나이벡 / 138610 / KRX:138610
Source: KRX statistical information